These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11859003)

  • 1. Potent nonsteroidal progesterone receptor agonists: synthesis and SAR study of 6-aryl benzoxazines.
    Zhang P; Terefenko EA; Fensome A; Zhang Z; Zhu Y; Cohen J; Winneker R; Wrobel J; Yardley J
    Bioorg Med Chem Lett; 2002 Mar; 12(5):787-90. PubMed ID: 11859003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel 6-aryl-1,4-dihydrobenzo[d]oxazine-2-thiones as potent, selective, and orally active nonsteroidal progesterone receptor agonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Zhang Z
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1313-6. PubMed ID: 12657271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Aryl-1,4-dihydro-benzo[d][1,3]oxazin- 2-ones: a novel class of potent, selective, and orally active nonsteroidal progesterone receptor antagonists.
    Zhang P; Terefenko EA; Fensome A; Wrobel J; Winneker R; Lundeen S; Marschke KB; Zhang Z
    J Med Chem; 2002 Sep; 45(20):4379-82. PubMed ID: 12238914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget.
    Fensome A; Bender R; Chopra R; Cohen J; Collins MA; Hudak V; Malakian K; Lockhead S; Olland A; Svenson K; Terefenko EA; Unwalla RJ; Wilhelm JM; Wolfrom S; Zhu Y; Zhang Z; Zhang P; Winneker RC; Wrobel J
    J Med Chem; 2005 Aug; 48(16):5092-5. PubMed ID: 16078826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists.
    Kern JC; Terefenko EA; Fensome A; Unwallla R; Wrobel J; Zhu Y; Cohen J; Winneker R; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2007 Jan; 17(1):189-92. PubMed ID: 17027272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 5-aryl-1,3-dihydro-indole-2-thiones. potent, orally active progesterone receptor agonists.
    Fensome A; Koko M; Wrobel J; Zhang P; Zhang Z; Cohen J; Lundeen S; Rudnick K; Zhu Y; Winneker R
    Bioorg Med Chem Lett; 2003 Apr; 13(7):1317-20. PubMed ID: 12657272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Achieving multi-isoform PI3K inhibition in a series of substituted 3,4-dihydro-2H-benzo[1,4]oxazines.
    Perry B; Alexander R; Bennett G; Buckley G; Ceska T; Crabbe T; Dale V; Gowers L; Horsley H; James L; Jenkins K; Crépy K; Kulisa C; Lightfoot H; Lock C; Mack S; Morgan T; Nicolas AL; Pitt W; Sabin V; Wright S
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4700-4. PubMed ID: 18644721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,5-Dihydro-benzo[e][1,4]oxazepin-2(1H)-ones containing a 7-(5'-cyanopyrrol-2-yl) group as nonsteroidal progesterone receptor modulators.
    Kern JC; Terefenko EA; Fensome A; Unwalla R; Wrobel J; Cohen J; Zhu Y; Berrodin TJ; Yudt MR; Winneker RC; Zhang Z; Zhang P
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5015-7. PubMed ID: 18722119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Aryl-1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal human progesterone receptor agonists.
    Zhi L; Tegley CM; Kallel EA; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):291-302. PubMed ID: 9464360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a new class of selective nonsteroidal progesterone receptor agonists.
    Dong Y; Roberge JY; Wang Z; Wang X; Tamasi J; Dell V; Golla R; Corte JR; Liu Y; Fang T; Anthony MN; Schnur DM; Agler ML; Dickson JK; Lawrence RM; Prack MM; Seethala R; Feyen JH
    Steroids; 2004 Mar; 69(3):201-17. PubMed ID: 15072922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Aryl indanones and derivatives as non-steroidal progesterone receptor modulators.
    Kern JC; Terefenko E; Trybulski E; Berrodin TJ; Cohen J; Winneker RC; Yudt MR; Zhang Z; Zhu Y; Zhang P
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6666-9. PubMed ID: 19864132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
    Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, resolution, and biological evaluation of 5-aryl-1, 2-dihydro-5H-chromeno[3,4-f]quinolines: potent, orally active, nonsteroidal progesterone receptor agonists.
    Edwards JP; Zhi L; Pooley CL; Tegley CM; West SJ; Wang MW; Gottardis MM; Pathirana C; Schrader WT; Jones TK
    J Med Chem; 1998 Jul; 41(15):2779-85. PubMed ID: 9667968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-Aryl-1,2-dihydro-5H-chromeno[3,4-f]quinolines as potent, orally active, nonsteroidal progesterone receptor agonists: the effect of D-ring substituents.
    Edwards JP; West SJ; Marschke KB; Mais DE; Gottardis MM; Jones TK
    J Med Chem; 1998 Jan; 41(3):303-10. PubMed ID: 9464361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-aryl 1,5-dihydro-benzo[e][1,4]oxazepin-2-ones and analogs as non-steroidal progesterone receptor antagonists.
    Zhang P; Kern JC; Terefenko EA; Fensome A; Unwalla R; Zhang Z; Cohen J; Berrodin TJ; Yudt MR; Winneker RC; Wrobel J
    Bioorg Med Chem; 2008 Jul; 16(13):6589-600. PubMed ID: 18504132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent, nonsteroidal selective androgen receptor modulators (SARMs) based on 8H-[1,4]oxazino[2,3-f]quinolin-8-ones.
    Higuchi RI; Thompson AW; Chen JH; Caferro TR; Cummings ML; Deckhut CP; Adams ME; Tegley CM; Edwards JP; López FJ; Kallel EA; Karanewsky DS; Schrader WT; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5442-6. PubMed ID: 17703938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-(3-Cyclopentyl-2-thioxo-2,3-dihydro-1H-benzimidazol-5-yl)-1-methyl-1H-pyrrole-2-carbonitrile: A novel, highly potent, selective, and orally active non-steroidal progesterone receptor agonist.
    Zhang P; Terefenko E; Kern J; Fensome A; Trybulski E; Unwalla R; Wrobel J; Lockhead S; Zhu Y; Cohen J; Lacava M; Winneker RC; Zhang Z
    Bioorg Med Chem; 2007 Oct; 15(20):6556-64. PubMed ID: 17681796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonsteroidal progesterone receptor modulators: structure activity relationships.
    Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
    Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel pyrrole-containing progesterone receptor modulators.
    Collins MA; Hudak V; Bender R; Fensome A; Zhang P; Miller L; Winneker RC; Zhang Z; Zhu Y; Cohen J; Unwalla RJ; Wrobel J
    Bioorg Med Chem Lett; 2004 May; 14(9):2185-9. PubMed ID: 15081005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Benzylidene 1,2-dihydrochromeno[3,4-f]quinolines, a novel class of nonsteroidal human progesterone receptor agonists.
    Tegley CM; Zhi L; Marschke KB; Gottardis MM; Yang Q; Jones TK
    J Med Chem; 1998 Oct; 41(22):4354-9. PubMed ID: 9784110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.